|
Lung Neoplasms
|
0.390 |
Therapeutic
|
group |
CTD_human |
Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation.
|
15981204 |
2005 |
|
Lung Neoplasms
|
0.390 |
GeneticVariation
|
group |
LHGDN |
Polymorphisms in the survivin gene and the risk of lung cancer.
|
17961802 |
2008 |
|
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Increased expression of survivin in gastric cancer patients and in first degree relatives.
|
12085263 |
2002 |
|
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer.
|
18251132 |
2008 |
|
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment.
|
11773702 |
2002 |
|
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Expression of survivin and caspase-3 in gastric cancer.
|
12643601 |
2003 |
|
Stomach Neoplasms
|
0.370 |
Biomarker
|
group |
CTD_human |
Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B.
|
15993841 |
2005 |
|
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.
|
15077160 |
2004 |
|
Stomach Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
|
16534839 |
2006 |
|
Stomach Neoplasms
|
0.370 |
Biomarker
|
group |
LHGDN |
Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection.
|
15457550 |
2004 |
|
Adenocarcinoma
|
0.360 |
Biomarker
|
group |
CTD_human |
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
|
26432044 |
2015 |
|
Adenocarcinoma
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
|
16826583 |
2006 |
|
Adenocarcinoma
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
|
16671090 |
2006 |
|
Adenocarcinoma
|
0.360 |
Biomarker
|
group |
BEFREE |
Then, using BIRC5 as a candidate, the prognostic value in LAD and TN adenocarcinomas was verified by the Kaplan-Meier plotter and The Cancer Genome Atlas (TCGA) database, respectively.
|
31093306 |
2019 |
|
Adenocarcinoma
|
0.360 |
AlteredExpression
|
group |
BEFREE |
The positive rate of EPR-1 expression in the primary gastric adenocarcinomas, invasion tumor node and lymph node metastasis was 65.83%, 55.29% and 68%, respectively.
|
15112339 |
2004 |
|
Adenocarcinoma
|
0.360 |
AlteredExpression
|
group |
BEFREE |
Specifically, we found that BIRC5, which codes for survivin, is upregulated in both adenocarcinoma and squamous cell carcinoma tissues and that high expression of BIRC5 is associated with poor survival in adenocarcinoma, but not squamous cell carcinoma.
|
29416000 |
2018 |
|
Adenocarcinoma
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
|
12168867 |
2002 |
|
Colorectal Neoplasms
|
0.360 |
Biomarker
|
group |
CTD_human |
Overexpression of thymosin beta-4 renders SW480 colon carcinoma cells more resistant to apoptosis triggered by FasL and two topoisomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively.
|
16364925 |
2006 |
|
Colorectal Neoplasms
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.
|
17641414 |
2007 |
|
Colorectal Neoplasms
|
0.360 |
Biomarker
|
group |
LHGDN |
T-cell responses to survivin in cancer patients undergoing radiation therapy.
|
18676762 |
2008 |
|
Colorectal Neoplasms
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Suppression of colorectal tumor growth by regulated survivin targeting.
|
17077982 |
2006 |
|
Colorectal Neoplasms
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
|
18670822 |
2008 |
|
Colorectal Neoplasms
|
0.360 |
AlteredExpression
|
group |
LHGDN |
Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
|
15809755 |
2005 |
|
Colorectal Neoplasms
|
0.360 |
Biomarker
|
group |
LHGDN |
Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor.
|
12654446 |
2003 |
|
Colonic Neoplasms
|
0.340 |
GeneticVariation
|
group |
LHGDN |
Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.
|
15685548 |
2005 |